SQAP

**SQAP** is a drug code name that appears in biomedical literature in the context of research but does not correspond to an approved pharmaceutical, biosimilar, or generic product. SQAP most commonly refers to *sulfoquinovosyl acylpropanediol*, a synthetic analog of sulfoquinovosyl diacylglycerols, which are natural sulfolipids found in membranes of plants and some bacteria. In preclinical research, SQAP acts as an **anti-tumor agent** and is thought to improve oxygen delivery or modify the tumor microenvironment by altering vascular permeability. Its mechanism may involve *extracellular matrix interaction*, *modulation of oxygen transport*, or targeting *hypoxia signaling* pathways, though exact molecular targets are not fully elucidated. SQAP has been mainly explored for **oncology** (cancer) indications. It is not an approved pharmaceutical, and no specific developer or manufacturer is listed in authoritative sources.

Brand names

SQAP

Other names

SQAP